GONADAL RADIATION-DOSE AND ITS GENETIC SIGNIFICANCE IN RADIOIODINE THERAPY OF HYPERTHYROIDISM
- 1 January 1976
- journal article
- research article
- Vol. 17 (9) , 826-835
Abstract
Published estimates of radiation dose to the gonads from 131I therapy of Graves'' disease vary widely, largely because of differences in assumptions regarding the details of iodine kinetics. The calculations described show that hyperthyroid patients treated with 10 mCi of 131I will usually receive a total radiation dose to the ovaries or testes of less than 3 rad. Several common roentgenographic diagnostic procedures may involve a greater radiation dose and a greater genetic hazard than does the usual 131I treatment for hyperthyroidism. It is important to minimize total exposure to radiation, but it seems unreasonable to deny 131I treatment for hyperthyroidism to young men and nonpregnant young women on the grounds of genetic hazard alone.This publication has 7 references indexed in Scilit:
- Kinetic Analysis of Iodine Metabolism1Journal of Clinical Endocrinology & Metabolism, 1966
- Fate of the Iodine Radioisotopes in the Human and Estimation of the Radiation ExposureHealth Physics, 1965
- Rising Incidence of Hypothyroidism after Radioactive-Iodine Therapy in ThyrotoxicosisNew England Journal of Medicine, 1964
- THE DISTRIBUTION OF I131IN TISSUE OBTAINED AT NECROPSY OR AT SURGICAL OPERATION IN MAN*Journal of Clinical Endocrinology & Metabolism, 1951
- THE DISTRIBUTION OF RADIOACTIVE IODINE IN HUMAN TISSUES: NECROPSY STUDY IN NINE PATIENTS*Journal of Clinical Endocrinology & Metabolism, 1950
- DOSAGE DETERMINATION WITH RADIOACTIVE ISOTOPES .2. PRACTICAL CONSIDERATIONS IN THERAPY AND PROTECTION1948
- THE URINARY EXCRETION OF RADIOIODINE IN VARIOUS THYROID STATESJournal of Clinical Investigation, 1947